BLRX Stock BioLineRx (BLRX, $3.38) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 20, 2025

GET DAILY SIGNALS

Get AI intraday signals

BLRX - BioLineRx Ltd

MACD signal

View

Odds of UP Trend

Price: $3.38

Daily change: +$0.05 (+1.5%)

Daily volume: 24.6K

Industry: Biotechnology

This is a Bullish indicator signaling BLRX's price could rise from here. Traders may explore going long the stock or buying call options. A.I. dvisor identified 45 similar cases where BLRX's MACD histogram became positive, and of them led to successful outcomes. Odds of Success:

BLRX's RSI Oscillator recovers from oversold territory

The RSI Indicator for BLRX moved out of oversold territory on November 05, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 36 similar instances when the indicator left oversold territory. In of the 36 cases the stock moved higher. This puts the odds of a move higher at .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 62 cases where BLRX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 28, 2025. You may want to consider a long position or call options on BLRX as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BLRX just turned positive on November 20, 2025. Looking at past instances where BLRX's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BLRX advanced for three days, in of 248 cases, the price rose further within the following month. The odds of a continued upward trend are .

BLRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 50-day moving average for BLRX moved below the 200-day moving average on November 19, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BLRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BLRX entered a downward trend on November 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.713) is normal, around the industry mean (27.247). P/E Ratio (0.000) is within average values for comparable stocks, (52.214). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.890). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.891) is also within normal values, averaging (320.114).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BLRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BLRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.